Update: The role of FoxP3 in allergic disease

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 16, Issue 3, 2008, Pages 275-279

  Paik, Young ^a   Dahl, Matthew ^a,b   Fang, Deyu ^a   Calhoun, Karen ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Allergic rhinitis; Asthma; CD4+CD25+ T regulatory cells; Forkhead box P3

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; ATOPY; CD4+ CD25+ T LYMPHOCYTE; DISEASE COURSE; GENE EXPRESSION; GENE FUNCTION; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY; T-LYMPHOCYTES;

EID: 43549105165     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3282ffabdc     Document Type: Review

References (30)

1. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. Assessing the economic impact. J Allergy Clin Immunol 2001; 107:3-8.
2. Tada T, Takemori T, Okumura K, et al. Two distinct types of helper T cells involved in the secondary antibody response: independent and synergistic effects of Ia- and Ia+ helper T cells. J Exp Med 1978; 147:446-458.
3. LaRosa DF, Orange JS. Lymphocytes. J Allergy Clin Immunol 2007; 121:S364-S369.
4. Buckner JH, Ziegler SF. Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res Ther 2004; 6:215-222.
5. Benson M, Wennergren G, Frannsson M, Cardell LO. Altered levels of the soluble IL-1, IL-4, and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitis. Int Arch Allergy Immunol 2004; 134:227-232.
6. Ramalingam TR, Reiman RM, Wynn TA. Exploiting worm and allergy models to understand Th2 cytokine biology. Curr Opin Allergy Clin Immunol 2005; 5:392-398.
7. Xu G, Mou Z, Jiang H, et al. A possible role of CD4+CD25+ T cells as well as transcription factor FoxP3 in the dysregulation of allergic rhinitis. Laryngoscope 2007; 117:876-880. The present study suggests that decreased expression of FoxP3 in Humans results in impaired and decreased amounts of CD4+CD25+ T-regulatory cells and therefore play a crucial role in immunological imbalance in allergic rhinitis.
8. Lee JH, Yu HH, Wang LC, et al. The levels of CD4+CD25+ regulatory T cells in pediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007; 148:53-63. The present study elucidated the correlation of severity of allergic rhinitis and asthma with the expression of FoxP3 and CD4+CD25+ T-regulatory cells.
9. Robinson DS, Larche M, Durham SR. Tregs and allergic disease. J Clin Invest 2004; 114:1389-1397.
10. Wilden RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy, and endocrinopathy syndrome is human equivalent of mouse scurfy. Nat Genet 2001; 27:18-20.
11. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutation of FoxP3. Nat Genet 2001; 27:20-21.
12. Torgerson TR, Linane A, Moes N, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FoxP3 gene. Gastroenterology 2007; 132:1705-1717.
13. Ono MY, Yaguchi H, Ohkura N, et al. FoxP3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007; 446:685-689. The present study showed the interaction of AML1/Runx1 with FoxP3 resulting in Treg cell upregulation and suppression of IFN-γ.
14. Dahl M. Decreased FoxP3 in allergic patients nasal secretions. American Academy of Otolaryngology: Allergy Annual Meeting; Washington, DC; 2007 [oral presentation]. The present study indicated reduced FoxP3 gene expression or impaired FoxP3 function is potentially responsible for allergic disease.
15. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531-562.
16. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3:253-257.
17. Fontenot JD, Rudensky A. A well adapted regulatory contrivance: the forkhead family transcription factor Foxp3 and regulatory T cell development. Nat Immunol 2005; 6:331-337.
18. Maggi L, Santarlasci V, Liotta F, et al. Demonstration of circulating allergen-specific CD4+CD25(high)FoxP3+ T-regulatory cells in both nonatopic and atopic individuals. J Allergy Clin Immunol 2007; 120:429-436. The present study shows CD4+25+FoxP3+ cells are capable of recognizing specific exogenous ubiquitous antigens in both atopic and nonatopic individuals.
19. Hartl D, Koller B, Mehlhorn AT, et al. Quantitative and functional impairment of pulmonary CD4+CD25(high) regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007; 119:1258-1266. The present study shows a decrease in the number of CD4+CD25+ T-regulatory cells in BALF of children with asthma. Additionally, the use of inhaled corticosteroids allowed for the CD4+CD25+ T-regulatory cells to become functional, indicating a therapeutic mechanism for further research.
20. Akdis M, Verhagen J, Taylor A. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199:1567-1575.
21. Shi HZ, Li S, Xie ZF, et al. Regulatory CD4+CD25+ T lymphocytes in peripheral blood from patients with atopic asthma. J Allergy Clin Immunol 2004; 113:172-178.
22. Ling EM, Smith T, Nguyen XD, et al. Relation of CD4CD25 regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363:608-615.
23. Grindebacke H, Wing K, Andersson AC, et al. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004; 34:1364-1372.
24. Morgan RK, McAllister B, Cross L, et al. Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. J Immunol 2007; 178:8081-8089. The present study reveals possible future therapeutic approach to treatment of allergic asthma via target of histamine receptors yielding CD4+CD25+ Treg cell recruitment and decreased airway inflammation.
25. Pereira-Santos MC, Baptiest AP, Melo A, et al. Expansion of circulating FoxP3+CD25bright CD4+ T cells during specific venom immunotherapy. Clin Exp Allergy 2008; 38:291-297.
26. Van Hove CL, Maes T, Joos GF, Tournoy KG. Prolonged inhaled allergen exposure can induce persistent tolerance. Am J Respir Cell Mol Biol 2007; 36:573-584. The present study utilizing the murine model compares Treg cell numbers during sensitization and tolerance in allergic airway inflammation.
27. Troukhova M, Seguin-Devaux C, Oris TB, et al. Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FoxP3. J Clin Invest 2005; 114:28-38.
28. Wu K, Bi Y, Sun K, et al. Suppression of allergic inflammation by allergen-DNA-modified dendritic cells depends on the induction of FoxP3+ regulatory T cells. Scand J Immunol 2008; 67:140-151.
29. Finotto S, Eigenbrod T, Karwot R, et al. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Int Immunol 2007; 19:685-693. The present study indicates another possible therapeutic target for treatment of asthma in the future.
30. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+25- naïve T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor FoxP3. J Exp Med 2003; 198:1875-1886.